A Study of Omalizumab in Preventing Bronchoconstriction Following Environmental Cat Dander Exposure in Patients With Cat Dander-induced Asthma

NCT00495612 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Omalizumab
DRUG: Placebo

Sponsor

Genentech, Inc.